Gen-Probe's Q1 Revenues up 7 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe today said that revenues for the first quarter rose 7 percent year over year as blood-screening revenues increased 12 percent.

The San Diego-based molecular diagnostics firm also announced a deal to be acquired by Hologic for $82.75 per share in cash for a total deal value of $3.7 billion.

Gen-Probe's revenues totaled $153.4 million, up from $143 million a year ago, and beating Wall Street estimates of $150.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.